Social Anxiety Nasal Spray Win; Racemic Ketamine vs Esketamine; Is AI Pro-Anorexia?

The investigational nasal spray fasedienol significantly improved social anxiety disorder symptoms during a public speaking challenge compared with placebo in the phase III PALISADE-2 trial, said developer Vistagen.

Only about one in five U.S. adults with past-year opioid use disorder received any medication to treat it in 2021. (JAMA Network Open)

High-frequency transcranial random noise stimulation plus cognitive training significantly reduced parent-reported attention deficit-hyperactivity disorder (ADHD) rating-scale scores compared with a control intervention in a trial of 23 newly diagnosed, drug-naive children. (Translational Psychiatry)

Greater exposure to air pollutants was tied to higher use of mental health services among people with dementia — particularly vascular dementia — in a retrospective cohort study. (BMJ Mental Health)

When used to treat major depression, racemic ketamine appeared more effective than esketamine in a meta-analysis of 49 trials. (eClinicalMedicine)

Kids are arriving at summer camps with more serious mental health issues than ever before. (New York Times)

Florida has “essentially banned” a high school advanced placement psychology course because of its content on sexuality. (Politico)

Artificial intelligence (AI) programs are spitting out pro-anorexia content. (Washington Post)

More and more psychiatrists are prescribing the weight-loss drug semaglutide (Wegovy) to help combat weight gain side effects associated with antipsychotics. (Reuters)

One in five children have experienced a stressful life event, according to data from the CDC’s 2021 National Health Interview Survey.

A Georgia State University researcher was awarded a $3.6 million grant to expand quality school-based mental health services for underserved populations in high-need schools.

Please enable JavaScript to view the

comments powered by Disqus.